Cross-Border Trade Guide
HS 3002 · HUMAN BLOOD; ANIMAL BLOOD; ANTISERA, VACCINES ETCAnnual bilateral volume: $448M
Estimated Duties
0-27%
Life-saving drugs 0%; else BCD 10% + Cess + IGST 12%
Transit Time
28-35 days
End to end
Compliance
CDSCO
Central Drugs Standard Control Org.
Export Rebate
0%
IVA zero-rated; IMMEX duty drawback available
DUTY CALCULATION — INDIA
Base Duty
20%
BCD 20% (smartphones)
SWS (10% of BCD)
+2%
IGST 18%
18%
on (CIF + duty)
Effective Total
~22%
duty only
| Product cost (FOB) | $100,000 |
| Ocean freight (est.) | $3,500 |
| Marine insurance (0.4%) | $400 |
| Import duty (20%) | $20,780 |
| SWS (10% of BCD) (2%) | $2,078 |
| IGST 18% on $126,758 | $22,816 |
| Landing charges (1%) | $1,000 |
| Customs broker | ~$100 |
| Estimated total landed cost | ~$150,674 |
* Estimates based on $100K FOB shipment of electronics (HS 85). Actual costs vary by exact HS code, weight/volume, and current rates.
Recent Advisories
Related analysis
Ten items as of June 3: USTR forced-labor §301 publishes concrete proposal — 60 economies, up to 12.5% (comments July 6, hearings July 7); 54 'failed to enforce' vs 6 'have but failed to enforce' tier split; Brazil §301 separately initiated June 1; §122 CAFC merits opinion most likely late 2026 (correcting May 29 deep-dive); CAPE — no paper checks since Feb 6, IOR without registered ACH = no refund; China State Council Order No. 834 (March 31) confirmed as the supply-chain security regulation; rare earths samarium/gadolinium/lutetium added Jan 1; §232 pharma 58 days; full July sequence locks in; Busan 160 days.
2026-06-03 · Read →Ten items as of May 31: US-Mexico round 1 closed May 29 with USTR joint readout — auto ROO, §232 steel/aluminum, economic security, and a new scope add (medical devices/pharma/cosmetics regulatory compatibility); Deputy USTR Jeffrey Gerrish led (not Greer); round 2 June 16-17 adds agriculture; round 3 week of July 20 slotted 4 days before §301 July 24 action; Canada track lagging — trilateral becomes de facto bilateral; §122 — CIT May 20 denied government stay but CAFC administrative stay holds; CAPE — ~1,880 refunds stuck on missing ACE ACH registration; §232 pharma 61 days; §301 54 days; CBAM Q2 36 days; Busan 163 days.
2026-05-31 · Read →Ten items as of May 28: §122 strikedown by CIT on May 7 is now confirmed by 10+ top firms (Proclamation 11012 invalidated, 2-1 split); CAFC May 12 administrative stay keeps §122 collected from everyone except 3 plaintiffs pending appeal; §122's two possible endings (CAFC reverses vs affirms) both resolve before §301 July 24; US-Mexico actual first round runs May 28-29 today/tomorrow with Deputy USTR Goettman leading; three-round schedule locked (5/28-29, 6/16-17, week of 7/20); CAPE first refunds expected to land week of June 2; §232 metals stable; 64 days to §232 pharma; 166 days to Busan expiry with the §122 judicial risk tightening pressure.
2026-05-28 · Read →Ten items as of May 26: Sheinbaum gave first US-Mexico round read ("advancing positively"); §122 is by design a bridge expiring July 24 when §301 takes over; single-source signal §122 may already be struck by CIT May 7 (flagged for verification); §301 178-product exclusions extended to November 10 (date-aligned with Busan); Beijing summit commercial deliverables (soybeans, Boeing) in execution; CAPE first refund landings still publicly unconfirmed but on-window; §232 metals tiered system stable in month two; 66 days to §232 pharma; 168 days to Busan expiry — the architectural timeline is now fully visible.
2026-05-26 · Read →Ten dated items as of May 22: Bessent May 19 Reuters names a ceiling (§301 restores but won't go higher); MOFCOM May 20 also names ceiling (Busan level is the redline); first concrete number — $30B per side reciprocal framework from May 12-13 Seoul talks; §301 16-economy investigation effectively becomes a China-only ceiling lock; Ebrard May 20 calls USMCA review a decade-plus annual cycle; US-Mexico May 25 agenda locked at 3 days out; CAPE first refunds not yet publicly confirmed; §232 pharma 70 days; Busan-truce 172 days with the framework numbers now visible.
2026-05-22 · Read →Ten dated items as of May 21: the Busan rare-earth promise is leaking — April yttrium oxide US exports at 10 tonnes vs 60 in March; MOFCOM May 20 reframes controls as 'lawful'; White House tacitly accepts; Greer pre-positions Mexico (tariffs never returning to zero) four days before May 25 round; CAPE refunds 3-5 weeks ACH from liquidation; no §232 Mexico carve-out; 71 days to §232 pharma; §301 forced-labor in determination; §301 excess-capacity narrowing toward China-only on hearing record; 173 days to Busan expiry with the first crack already visible.
2026-05-21 · Read →Ten dated items as of May 19: Trump-Xi Beijing summit landed May 14-15 heavy on symbolism ($17B/yr soybeans, 200 Boeing, two new bilateral committees), rare-earths named only in US communiqué not China's, CAPE Phase 1 at 15.1M validated and $35.46B refund pool with Treasury disbursing May 12, US-Mexico bilateral opens May 25 with 52 US demands on the table, July 1 trilateral review unlikely to conclude on time, US average effective rate on China at ~31.6% base, §232 pharma 73 days from kickoff, CAPE Phase 2 timing undisclosed, forced-labor §301 entering determination, 175 days to Busan expiry.
2026-05-19 · Read →Ten dated items as of May 6: §301 excess-capacity day-one testimony aimed at China while pushing to drop the other 15, CAPE's first IEEPA refund Monday, forced-labor §301 rebuttals due Friday, Eaton's next CBP progress report May 12, US-Mexico bilateral May 25, leaked Mexican retaliation list 5–20%, Canadian Liberal minority govt April 28, US average effective tariff at 11.8% (highest since early 1940s), §301 maritime vessel fees in force since April 17, and 188 days to Busan-truce expiry.
2026-05-06 · Read →Ten dated, sourced items shaping cross-border trade as of May 3: §301 excess-capacity hearings open Monday, CAPE Phase 1 throughput at 3% in stage, May 25 US-Mexico bilateral, §232 full-value methodology one month in, pharma 100% on calendar, Mexico textile decree sunset, CBAM Q2 due July 6, single-source PRC retaliation cluster, and 191 days to the Busan-truce expiry.
2026-05-03 · Read →Every trade publication led with the steel numbers on April 2. The second §232 signed the same afternoon puts 100% ad valorem on patented pharmaceuticals — with Switzerland at 15%, Ireland and India at the default rate, generics exempt, and a July 31 deadline for 17 named companies.
2026-04-22 · Read →